What does 'not capturing' indicate in a leadless pacemaker, and how should it be evaluated and managed?

Leadless Pacemaker Not Capturing: Definition and Management

"Not capturing" in a leadless pacemaker means the device delivers a pacing impulse but fails to produce a mechanical ventricular contraction—a potentially life-threatening situation in pacemaker-dependent patients that requires immediate ECG monitoring and device interrogation.

What "Not Capturing" Means

Loss of capture occurs when you see a pacing spike on the ECG but no subsequent QRS complex follows. The electrical impulse from the pacemaker fails to depolarize the myocardium sufficiently to generate a heartbeat 1. This is distinct from failure to sense (where the device doesn't detect intrinsic cardiac activity) or failure to pace (where no spike appears at all).

Immediate Evaluation Steps

1. Assess Patient Stability and Pacemaker Dependency

• Check for hemodynamic instability—hypotension, altered mental status, syncope
• Determine if the patient has pacemaker dependency (unstable or absent spontaneous rhythm with hemodynamic instability in the absence of pacing) 1
• If pacemaker-dependent and unstable: This is a medical emergency requiring immediate intervention

2. Verify Capture on ECG

• Look for pacing spikes followed by QRS complexes
• Check multiple ECG leads—the pacing artifact may obscure the QRS in some leads 2
• Confirm mechanical capture using pulse oximetry plethysmogram or arterial line, not just ECG 2

3. Immediate Device Interrogation

Interrogate the leadless pacemaker to assess 3, 4:

• Pacing threshold: Has it increased above programmed output?
• Lead impedance: Abnormal values suggest device malposition or perforation
• Battery status: Near end-of-life can cause capture failure
• Sensing parameters: Rule out oversensing causing inappropriate inhibition

Timing-Based Differential Diagnosis

Acute Loss of Capture (Days to Weeks Post-Implant)

The most common cause is device dislodgement or malposition 1, 4. For leadless pacemakers specifically:

• Lack of active fixation mechanisms increases dislodgement risk compared to traditional leads 1
• Cardiac perforation through the right ventricular free wall or interventricular septum 1
• Exit block at the electrode-myocardium interface

Action: Chest X-ray (PA and lateral) to compare device position with immediate post-implant films 3. Device repositioning or replacement may be required.

Subacute to Chronic Loss of Capture (Months to Years)

Increased pacing threshold is the primary concern 1, 4:

• Myocardial fibrosis at the electrode site
• Metabolic derangements: hyperkalemia, severe acidosis, hypothyroidism
• Medications: class IC antiarrhythmics (flecainide, propafenone), class III agents (amiodarone)
• Myocardial ischemia: Can acutely increase threshold 5
• Lead fracture (less relevant for leadless devices but can occur)

Action:

• Correct metabolic abnormalities (check potassium, pH, thyroid function)
• Review medications for threshold-elevating drugs
• Consider stress testing if ischemia suspected 5
• Reprogram to higher output if threshold elevated but device has adequate safety margin

Management Algorithm

For Pacemaker-Dependent Patients

1. Immediate: Apply transcutaneous pacing pads as backup 2
2. Pharmacologic support: Initiate chronotropic drug infusion (isoproterenol, epinephrine) if no contraindication 6
3. Continuous ECG monitoring with pulse oximetry or arterial line 1, 2
4. Device interrogation and reprogramming: Increase output to 2× threshold with minimum 2.5V 7
5. If reprogramming fails: Prepare for temporary transvenous pacing or device replacement

For Non-Pacemaker-Dependent Patients

1. Continuous ECG monitoring for 12-24 hours 1
2. Device interrogation to identify cause
3. Reprogram to asynchronous mode (VOO) if electromagnetic interference suspected 8, 9
4. Address reversible causes: electrolytes, medications, ischemia
5. Schedule elective device revision if threshold permanently elevated beyond device capability

Critical Pitfalls to Avoid

• Don't assume capture from ECG alone: Large pacing artifacts can mimic QRS complexes. Always confirm mechanical capture with pulse check or plethysmography 2
• Don't delay in pacemaker-dependent patients: Loss of capture can cause asystole and death. Have backup pacing immediately available 1
• Don't forget rate-dependent capture failure: Some patients lose capture only at higher pacing rates 10. Test at multiple rates during interrogation.
• Don't overlook myocardial ischemia: Acute coronary syndrome can increase pacing threshold and cause intermittent capture loss 5
• Don't ignore electromagnetic interference: Electrocautery, MRI, and other sources can cause temporary or permanent capture failure 8, 9, 6

Monitoring Duration

ECG monitoring is recommended for 12-24 hours after leadless pacemaker implantation in all patients 1. For patients experiencing loss of capture, continue monitoring until the issue is definitively resolved and stable capture is confirmed at multiple pacing rates 2.

The key distinction with leadless pacemakers is their higher risk of dislodgement due to lack of active fixation mechanisms compared to traditional transvenous leads, making early post-implant monitoring particularly critical 1.